Boehringer Ingelheim Secures U.S. Approval for Groundbreaking Lung Cancer Drug,
Boehringer Ingelheim has received approval from U.S. regulatory authorities for its new drug aimed at treating a difficult form of lung cancer. This authorization marks a significant milestone for the…